Logo image of ALBI.PA

GASCOGNE (ALBI.PA) Stock Fundamental Analysis

EPA:ALBI - Euronext Paris - Matif - FR0000124414 - Common Stock - Currency: EUR

2.32  -0.03 (-1.28%)

Fundamental Rating

2

Overall ALBI gets a fundamental rating of 2 out of 10. We evaluated ALBI against 12 industry peers in the Containers & Packaging industry. ALBI may be in some trouble as it scores bad on both profitability and health. ALBI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALBI has reported negative net income.
ALBI had a positive operating cash flow in the past year.
In the past 5 years ALBI has always been profitable.
In the past 5 years ALBI always reported a positive cash flow from operatings.
ALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

1.2 Ratios

ALBI has a Return On Assets of 1.82%. This is in the lower half of the industry: ALBI underperforms 66.67% of its industry peers.
ALBI has a Return On Equity of 5.01%. This is in the lower half of the industry: ALBI underperforms 66.67% of its industry peers.
With a Return On Invested Capital value of 3.31%, ALBI perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALBI is below the industry average of 8.29%.
Industry RankSector Rank
ROA 1.82%
ROE 5.01%
ROIC 3.31%
ROA(3y)3.28%
ROA(5y)2.91%
ROE(3y)8.45%
ROE(5y)7.66%
ROIC(3y)5.35%
ROIC(5y)4.85%
ALBI.PA Yearly ROA, ROE, ROICALBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 2.35%, ALBI is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ALBI has remained more or less at the same level.
ALBI has a Operating Margin (4.39%) which is comparable to the rest of the industry.
ALBI's Operating Margin has improved in the last couple of years.
ALBI has a worse Gross Margin (26.41%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of ALBI has remained more or less at the same level.
Industry RankSector Rank
OM 4.39%
PM (TTM) 2.35%
GM 26.41%
OM growth 3Y-1.09%
OM growth 5Y3.7%
PM growth 3Y0.74%
PM growth 5Y0.09%
GM growth 3Y-4.19%
GM growth 5Y-1.19%
ALBI.PA Yearly Profit, Operating, Gross MarginsALBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

2

2. Health

2.1 Basic Checks

ALBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ALBI has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALBI remains at a similar level compared to 5 years ago.
The debt/assets ratio for ALBI is higher compared to a year ago.
ALBI.PA Yearly Shares OutstandingALBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ALBI.PA Yearly Total Debt VS Total AssetsALBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

ALBI has an Altman-Z score of 1.55. This is a bad value and indicates that ALBI is not financially healthy and even has some risk of bankruptcy.
ALBI has a Altman-Z score of 1.55. This is in the lower half of the industry: ALBI underperforms 75.00% of its industry peers.
ALBI has a Debt/Equity ratio of 0.89. This is a neutral value indicating ALBI is somewhat dependend on debt financing.
ALBI has a Debt to Equity ratio of 0.89. This is in the lower half of the industry: ALBI underperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACC0.78
WACC4.23%
ALBI.PA Yearly LT Debt VS Equity VS FCFALBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.47 indicates that ALBI should not have too much problems paying its short term obligations.
ALBI's Current ratio of 1.47 is in line compared to the rest of the industry. ALBI outperforms 41.67% of its industry peers.
ALBI has a Quick Ratio of 1.47. This is a bad value and indicates that ALBI is not financially healthy enough and could expect problems in meeting its short term obligations.
ALBI has a Quick ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.78
ALBI.PA Yearly Current Assets VS Current LiabilitesALBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.17%.
The Earnings Per Share has been decreasing by -1.29% on average over the past years.
ALBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.41%.
Measured over the past years, ALBI shows a small growth in Revenue. The Revenue has been growing by 0.46% on average per year.
EPS 1Y (TTM)-131.17%
EPS 3Y5.42%
EPS 5Y-1.29%
EPS Q2Q%-156.67%
Revenue 1Y (TTM)-16.41%
Revenue growth 3Y4.65%
Revenue growth 5Y0.46%
Sales Q2Q%-14.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBI.PA Yearly Revenue VS EstimatesALBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
ALBI.PA Yearly EPS VS EstimatesALBI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBI.PA Price Earnings VS Forward Price EarningsALBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALBI is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.97
ALBI.PA Per share dataALBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GASCOGNE

EPA:ALBI (3/7/2025, 7:00:00 PM)

2.32

-0.03 (-1.28%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap87.42M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 2.59
P/B 0.45
P/tB 0.48
EV/EBITDA 4.97
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)0.89
OCFY38.54%
SpS10.91
BVpS5.13
TBVpS4.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.82%
ROE 5.01%
ROCE 4.94%
ROIC 3.31%
ROICexc 3.75%
ROICexgc 3.89%
OM 4.39%
PM (TTM) 2.35%
GM 26.41%
FCFM N/A
ROA(3y)3.28%
ROA(5y)2.91%
ROE(3y)8.45%
ROE(5y)7.66%
ROIC(3y)5.35%
ROIC(5y)4.85%
ROICexc(3y)6.01%
ROICexc(5y)5.49%
ROICexgc(3y)6.27%
ROICexgc(5y)5.71%
ROCE(3y)8.35%
ROCE(5y)7.53%
ROICexcg growth 3Y-8.76%
ROICexcg growth 5Y-7.39%
ROICexc growth 3Y-8.7%
ROICexc growth 5Y-7.69%
OM growth 3Y-1.09%
OM growth 5Y3.7%
PM growth 3Y0.74%
PM growth 5Y0.09%
GM growth 3Y-4.19%
GM growth 5Y-1.19%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 4.42
Cap/Depr 392.61%
Cap/Sales 19.87%
Interest Coverage 3.64
Cash Conversion 86.73%
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.78
Altman-Z 1.55
F-Score4
WACC4.23%
ROIC/WACC0.78
Cap/Depr(3y)251.08%
Cap/Depr(5y)214.45%
Cap/Sales(3y)12.1%
Cap/Sales(5y)9.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.17%
EPS 3Y5.42%
EPS 5Y-1.29%
EPS Q2Q%-156.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.41%
Revenue growth 3Y4.65%
Revenue growth 5Y0.46%
Sales Q2Q%-14.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.85%
EBIT growth 3Y3.5%
EBIT growth 5Y4.18%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-487.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.96%
OCF growth 3Y12.15%
OCF growth 5Y33.28%